$0.96
-0.0499 (-4.94%)
At Close: Jun 03, 2026
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Coronavirus threatens future of eurozone, Brussels warns
03:55pm, Wednesday, 06'th May 2020
Pandemic risks exacerbating economic and social divisions between countries
InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12
12:00pm, Tuesday, 05'th May 2020
TEL AVIV, Israel, May 05, 2020 -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid.
Equinix: In A Single Metric
09:05pm, Friday, 01'st May 2020
Equinix shares have recently reached their 52wk high, in spite of market turbulence. We believe EQIX is benefiting from secular trends, but also unique among da
Kraft Heinz Posts Upbeat Q1 Sales Due to Pandemic-Led Demand
05:14pm, Thursday, 30'th Apr 2020
Kraft Heinz delivered better-than-expected results for the first quarter. The company benefited from pantry loading amid the COVID-19 pandemic.
Edited Transcript of NSPR earnings conference call or presentation 10-Mar-20 12:30pm GMT
09:10pm, Tuesday, 07'th Apr 2020
Q4 2019 InspireMD Inc Earnings Call
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:16am, Monday, 06'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR), IDEAYA Biosciences (IDYA) and Capricor
InspireMD, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
01:13pm, Thursday, 12'th Mar 2020
Shareholders in InspireMD, Inc. (NYSEMKT:NSPR) had a terrible week, as shares crashed 33% to US$0.64 in the week since...
Analysts Offer Insights on Healthcare Companies: InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK)
11:31am, Wednesday, 11'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK) with
H.C. Wainwright Reiterates Buy on InspireMD, Lowers Price Target to $2
12:00am, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
InspireMD Announces Fourth Quarter and Year-End 2019 Financial Results
12:00pm, Tuesday, 10'th Mar 2020
Robust CGuard™ EPS year-over-year revenue growth of 31% Management to host investor conference call today, March 10, at 8:30am ET TEL AVIV, Israel, March 10, 2020 --.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Sign In
Buy NSPR